Publications by authors named "Jan Birzele"
Introduction: The American Association for the Surgery of Trauma (AAST) renal trauma grading leads to a variable management of patients with high-grade renal injuries. For a better prediction of the risk for bleeding interventions, Keihani et al. introduced the multi-institutional genito-urinary trauma study (MiGUTS) renal trauma nomogram in 2019.
View Article and Find Full Text PDFArticle Synopsis
- - The report describes a rare case of a 36-year-old male who developed bacterial abscess-forming prostatitis while being treated with adalimumab for hidradenitis suppurativa, presenting with anogenital pain and dysuria.
- - Initial treatment included antibiotics after suspicion of acute prostatitis; however, further imaging revealed a complex abscess linked to the prostate, leading to the need for drainage and intensive antibiotic therapy.
- - The case underscores the importance of monitoring for adverse effects from immunomodulating drugs and suggests that physicians should remain vigilant and prompt in their diagnostic approach to similar uncommon presentations.
Purpose: The primary objective of this preliminary study was to assess the changes in concentration of biomarkers, which indicate renal injury, after RIRS.
Materials And Methods: Within this prospective study, we included 21 patients with nephrolithiasis requiring treatment with RIRS. From each patient, blood and urine samples were taken at fixed intervals before and after RIRS.
Background: Urinary incontinence is a major concern for patients scheduled for radical prostatectomy. However, after prostatectomy lower urinary tract symptoms (LUTS) may improve and thus mitigate this concern. We assessed LUTS and its interference with the quality of life (QoL) using the short form of the international continence society male questionnaire (ICSMALESF-Q) in patients before and after robot-assisted radical prostatectomy (RARP).
View Article and Find Full Text PDFPurpose: Patients with multiple sclerosis often experience overactive bladder symptoms. High dose intradetrusor botulinum toxin A treatment is effective but often results in urinary retention and urinary diversion via a catheter. In this pilot study we evaluated whether only 100 U botulinum toxin A would significantly decrease overactive bladder symptoms in patients with multiple sclerosis without impairing pretreatment voluntary voiding.
View Article and Find Full Text PDF